Recall events
/
Event 73560
Event summary
Timeline bucket January 20, 2015
Product types Drug
Classifications Class I
Statuses Terminated
Recalling firm wording Pacifico National, Inc. dba AmEx Pharmacy
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Avastin (Bevacizumab) 2 mg/0.08 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.
D-0869-2016
Recall number D-0869-2016
Initiated January 20, 2015
Classification Class I
Status Terminated
Quantity 45 syringes
App-derived interpretation
Microbial contamination
reason.microbial_contamination · v1.0.0
bacterial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Non-Sterility: Product tested positive for bacterial contamination.
Code information Lot #: 141224C, Exp. 03/24/2015; 150915B, Exp. 12/14/2015
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8583]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Avastin (Bevacizumab) 1.25 mg/0.05 mL syringe, Office Administration Only, AmEx Pharmacy, 1515 Elizabeth St Suite J, Melbourne, FL 32901.
D-0870-2016
Recall number D-0870-2016
Initiated January 20, 2015
Classification Class I
Status Terminated
Quantity 836 syringes
App-derived interpretation
Microbial contamination
reason.microbial_contamination · v1.0.0
bacterial contamination
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Non-Sterility: Product tested positive for bacterial contamination.
Code information Lot #: 150116B, Exp. 04/16/2015; 150119R, Exp. 04/19/2015; 150316H, Exp. 06/14/2015
Distribution pattern Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9327]
FDA event record
· Exact recall-number query on openFDA